BPI-452080 / Betta Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BPI-452080 / Betta Pharma
NCT05843305: A Study of BPI-452080 in Subjects With Solid Tumors

Not yet recruiting
1
87
RoW
BPI-452080
Betta Pharmaceuticals Co., Ltd.
Solid Tumor, Renal Cell Carcinoma, Von Hippel-Lindau Disease
03/25
10/25

Download Options